Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: marcher who wrote (177329)	8/27/2021 4:29:22 AM
From: TobagoJack	1 Recommendation Recommended By marcher Read Replies (1) \| Respond to of 217561

Re <<seems that you deserve an expert crown for something....>> whilst I hope I am wrong on making hunches w/r to Covid vaccines, but the last few hours seems to indicate that the conventional narrative might be somewhere between quite- to very-extremely wrong. As earlier noted, natural immunity gained from infection by virus should be good for awhile, and if so, immunity from deactivated virus ought to be the next best. As Israel and UK demonstrated, the other liquids might be just liquids, and one is now a FDA-approved liquid. Should it turn out that BioNTech is just and only a liquid, and unable to stand up to the rigours of onsetting autumn and soon-to-be winter, what then? Besides not-priced-in, more viral printing of money and viral loading of debt. I am afraid. I am only somewhat immunised against money dilution, and not at all against the virus, unless my encounter with strange flu back in November 2019 was you-know-what. But if you-know-what, whilst it was bad, it was survivable. No idea. Remaining agnostic. Agnostic is healthy. Can Teams Biden, Modi, Johnson, and Morrison get on the phone w/ Core Comrade Jinping or President Putin and ask for some vaccines in a hurry? It would be rather unseemly of the Indo-Pacific QUAD. If the answer is 'no', will AZ, Pfizer, Moderna, and Johnson & Johnson offer up deactivated virus vaccine at some point soon? I define 'soon' as before the onset of the flu season, in the next 40 days, in time to get some deliveries before end-November. Message 33458328 siliconinvestor.com Btw, the '50%' that the suspect MSM keeps repeating was never a trial result. It was a number released by the company at one early point that featured an adjective, 'at least [50%]' meaning the vaccine is useful. The Sinovac shot’s efficacy ranged from a little over 50% to 83.5% across a number of testing sites in late-stage trials. bloomberg.com Sinopharm, Sinovac Shots Remained Protective in Guangdong Outbreak, Chinese Researchers Say 27 August 2021, 15:30 GMT+8 China’s inactivated vaccines maintained their protective power during a recent outbreak of Covid-19 in the southern Chinese province of Guangdong, providing real world evidence about their ability to stave off the highly infectious delta variant. The immunizations from state-owned Sinopharm and Sinovac Biotech Ltd. had a combined effectiveness of 70% against pneumonia caused by Covid and completely protected against severe disease caused by the delta variant, according to a pre-print study from researchers with the Guangdong Provincial Center for Disease Control and Prevention. The paper hasn’t yet been reviewed by outside experts. The paper tracked more than 10,000 people, including those infected and their close contacts during the outbreak that started in late-May and ended in mid-June. A total of 167 people contracted the virus. About one in eight of those in the study were fully vaccinated, mostly with shots from Sinopharm and Sinovac, and just over half were unvaccinated. The remainder had received at least one shot but came into close contact someone who was infected before they had time to fully build up their immunity. The research is the first real world examination of the potency of Chinese shots against the delta strain that is driving a resurgence of disease around the world. It comes amid questions about the effectiveness of the Chinese vaccines compared to those made elsewhere, as evidence emerges that some rival shots have less potency when trying to ward off delta infections. Widely UsedBoth the Sinopharm and Sinovac vaccines have been widely used across China and much of the developing world. Millions more doses will be supplied globally through the Covax program backed by the World Health Organization to countries struggling to get enough shots to immunize their people. The study evaluated the ability of the Chinese shots to prevent fully vaccinated people from developing pneumonia or severe disease caused by Covid. The design makes it difficult to directly compare them to western shots, such as the mRNA vaccine from Pfizer Inc. or the viral vector immunization from AstraZeneca Plc. Those inoculations were found to be 88% and 67% effective against symptomatic infections caused by the delta variant in an English study, and all appear to be highly effective against severe disease. The two inactivated Sinopharm shots were originally found to be 78% and 73% effective against symptomatic disease in pivotal trials earlier in the outbreak, before delta was circulating. The Sinovac shot’s efficacy ranged from a little over 50% to 83.5% across a number of testing sites in late-stage trials. — With assistance by John Liu, and Dong Lyu Before it's here, it's on the Bloomberg Terminal. LEARN MORE